VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EYE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EYENational Vision Holdings, Inc.
$17.60$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEYECash Flow

National Vision Holdings, Inc. (EYE) Cash Flow Statement

11Y historyFree accessUpdated daily

Operating cash flow of $65.1M in 2026Q3 exceeded net income of $19.2M by a 3.39 conversion ratio, but quarterly free cash flow swung from -$14.1M to $49.3M, suggesting working capital timing may be flattering recent results.

Income StatementBalance SheetCash FlowRatios

EYE Cash Flow Statement

Annual statement

EYE Cash Flow Statement

National Vision Holdings, Inc. (EYE) cash flow statement — 11-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Cash from Operations148.03M146.29M133.65M173.03M119.2M258.94M234.98M165.08M106.63M90.25M97.59M83.13M
Operating CF Margin %-7.36%7.33%8.14%7.25%12.45%13.73%9.57%6.94%6.56%8.16%7.82%
Operating CF Growth %-10.69%9.46%-22.76%45.16%-53.97%10.2%42.34%54.82%18.14%-7.52%17.39%-
Net Income66.1M29.6M-28.5M-65.9M42.12M128.24M36.28M32.8M23.65M45.82M14.76M3.62M
Depreciation & Amortization92.78M99.89M99.08M101.42M99.96M101.8M91.58M87.24M74.34M61.97M51.99M44.07M
Stock-Based Compensation1.47M23.69M16.71M20.17M13.51M14.89M10.74M12.67M20.94M5.15M4.29M6.63M
Deferred Taxes5.13M4.66M-9.97M-5.99M11.02M16.7M-233K-2.38M-19.34M-39.73M11.18M1.53M
Other Non-Cash Items69.57M8.48M45.56M92.09M-2.79M3.32M47.86M37.84M33.07M29.58M12.07M19.98M
Working Capital Changes-69.31M-20.03M10.77M31.24M-44.63M-6.02M48.76M-3.09M-26.03M-12.54M3.3M7.3M
Change in Receivables5.21M-8.07M36.4M-7.82M-24.82M1.18M-13.7M-6.92M-14.65M-16.86M-5.02M-6.85M
Change in Inventory-41.64M-728K21.6M-457K-1.86M-14.88M11.43M-15.89M-28.74M-9.58M-12.1M-10.66M
Change in Payables1.73M25.36M-13.91M2.28M945K-530K24.08M-2.86M7.93M-3.69M5.62M-82K
Cash from Investing-74.79M-76.61M-96.09M-115.82M-110.89M-92.9M-76.41M-100.63M-104.22M-94.83M-91.66M-80.05M
Capital Expenditures-7.04M-72.84M-95.5M-114.77M-113.55M-95.52M-76.82M-101.33M-104.49M-93.22M-90.03M-77.16M
CapEx % of Revenue0.34%3.66%5.24%5.4%6.9%4.59%4.49%5.88%6.8%6.78%7.53%7.26%
Acquisitions000000000000
Investments------------
Other Investing-67.75M-3.77M-589K-1.05M2.65M2.62M413K694K272K-108K-638K-44K
Cash from Financing-69.42M-104.62M-113.34M-136.81M-84.56M-234.32M176.28M-42.14M10.4M3.84M-6.57M-4.32M
Debt Issued (Net)-18.59M-104.81M-110.06M-106.92M-3.91M-171.97M176.3M-28.33M-6.08M-193.68M-7.1M142.05M
Equity Issued (Net)-49.16M190K-1.58M-26.58M-80.64M-61.46M12.42M-10.88M-1.93M373.02M559K110K
Dividends Paid000000000-170.98M0-145.67M
Share Repurchases-52.65M-3.21M-3.09M-28.41M-84.39M-73.3M-689K-25.65M-1.93M0-188K0
Other Financing-1.67M0-1.7M-3.31M0-900K-12.44M-2.93M18.4M-4.53M-31K-809K
Net Change in Cash3.67M-35.24M-75.79M-79.6M-76.25M-68.28M334.85M22.31M12.8M-737K-650K-1.24M
Free Cash Flow68.15M73.45M38.14M58.26M5.65M163.42M158.16M63.76M2.13M-2.97M7.56M5.97M
FCF Margin %3.31%3.7%2.09%2.74%0.34%7.86%9.24%3.7%0.14%-0.22%0.63%0.56%
FCF Growth %-17.84%92.57%-34.53%930.95%-96.54%3.33%148.07%2886.23%171.96%-139.24%26.58%-
FCF per Share0.850.910.490.740.071.701.910.780.03-0.050.100.08
FCF Conversion (FCF/Net Income)1.03x4.94x-4.69x-2.63x2.83x2.02x6.48x5.03x4.51x1.97x6.61x22.98x
Interest Paid3.67M19.09M13.4M11.73M16.94M24.9M30.79M33.94M33.47M47.09M34.87M33.39M
Taxes Paid2.16M21.15M6.33M7.57M7.48M10.43M894K684K1.45M2.65M415K365K

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Thin margins and optometrist shortage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Flow Diverges From Thin Earnings

Based on EYE's reported quarterly figures, operating cash flow exceeded net income in most recent periods, with 2026Q3 OCF of $65.1M against $19.2M net income, a 3.39 conversion ratio that suggests earnings quality is being flattered by non-cash items or working capital timing.

The conversion ratio is volatile, ranging from 0.65 in 2026Q2 to 13.83 in 2025Q3, which indicates that quarterly net income is too small and noisy to serve as a stable anchor for cash generation. The gap between a 1.5% net margin and consistently positive operating cash flow suggests that depreciation of $22-23M per quarter is doing much of the work, so investors should monitor whether maintenance-level cash generation holds if store reinvestment rises. The 2024 quarters, where net losses coincided with positive OCF, reinforce that reported earnings alone do not capture the business's cash economics.

Free Cash Flow Turns Positive but Lumpy

According to reported quarterly cash flow statements, EYE free cash flow reached $49.3M in 2026Q3 at a 9.7% margin, though the trajectory swung from -$14.1M in 2026Q2 to a $44.1M rebound in 2026Q1, indicating the recovery is not yet linear.

Free cash flow margins across the ten-quarter window have oscillated between roughly -2.8% and 9.7%, which points to working capital movements and timing rather than a clear structural improvement in cash generation. The recent sequence of strong quarters is encouraging, but a single positive quarter does not establish a durable trend, and investors should look for several consecutive quarters above 6% before treating the margin as sustainable. Capex intensity relative to revenue has been moderating in the latest quarters, which may partly explain the improvement in FCF.

Working Capital Swings Drive Quarterly Volatility

As reported in EYE's cash flow statements, working capital changes ranged from -$40.3M in 2026Q2 to +$18.3M in 2025Q2, a swing large enough to dominate quarterly operating cash flow and obscure the underlying earnings trend.

The magnitude of working capital movements relative to quarterly net income suggests that receivable collection, inventory build for lens and frame stock, and the timing of unearned revenue are material drivers of cash flow. Given that revenue is recognized at pickup rather than at exam, the balance between unearned revenue and receivables may shift meaningfully with patient flow, which warrants further investigation. Investors should treat single-quarter operating cash flow as unreliable and focus on trailing averages.

Capex Discipline Versus Store Reinvestment Needs

Based on reported figures, EYE capital expenditure fell to 3.1% of revenue in 2026Q3 from 9.6% in 2025Q4, with quarterly capex ranging between $11.8M and $48.4M, a range that makes it difficult to separate maintenance from growth spending.

A capex-to-revenue ratio near 3% is consistent with a mature store base requiring limited new build-out, yet the spike to 9.6% in 2025Q4 suggests lumpy investment in lab automation or store remodels that may be discretionary. With D&A running at roughly $22-23M per quarter, capex in the $15-20M range in most recent quarters appears to be below depreciation, which may indicate under-investment that could raise future maintenance needs, though this remains an inference rather than a confirmed finding.

Limited Capital Returns Amid Share Repurchases

According to reported cash flow statements, EYE paid no dividends across the ten quarters and directed buybacks of roughly $10-21M in recent quarters, with 2026Q3 repurchases of $21.4M absorbing a significant share of the $49.3M free cash flow.

The absence of dividends and the consistent use of cash for repurchases suggest management is prioritizing equity return mechanisms over income distribution, consistent with a leveraged balance sheet and thin ROE of 3.5%. Repurchasing stock with free cash flow that is only modestly positive raises the question of whether buybacks are being funded from balance sheet liquidity during weaker quarters, which warrants further investigation given the Debt/Equity ratio of 0.80.

Strong Quarters May Mask Fragile Cash Base

Based on reported quarterly figures, the strongest EYE cash quarters, including 2026Q3 OCF of $65.1M, may reflect timing benefits rather than durable generation, as cumulative free cash flow across the ten quarters remains modest relative to revenue.

Summing the reported quarters, positive free cash flow in several periods is largely offset by negative quarters such as 2024Q2 and 2026Q2, suggesting the business has not yet demonstrated consistent cash compounding. Working capital inflows in a few quarters may be pulling forward cash that reverses later, which warrants further investigation before treating the recent run of positive results as a structural shift. Investors should weigh whether the buyback pace is sustainable if quarterly free cash flow reverts toward the low single-digit margins seen earlier in the window.

EYE — Frequently Asked Questions

Quick answers to the most common questions about buying EYE stock.

How much cash does National Vision Holdings, Inc. (EYE) generate from operations?

National Vision Holdings, Inc. (EYE) generated $146.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is National Vision Holdings, Inc.'s free cash flow?

National Vision Holdings, Inc. (EYE) generated $73.5M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is National Vision Holdings, Inc.'s capital expenditure (CapEx)?

National Vision Holdings, Inc. (EYE) spent $72.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does National Vision Holdings, Inc. distribute cash to shareholders?

In 2025, National Vision Holdings, Inc. (EYE) spent $3.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.